Immune cells track hard-to-target brain tumours.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 30622348.
- Also identified by DOI 10.1038/d41586-018-07728-9 and PMC identifier 6532058.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Clinical trials reveal that personalized vaccines can boost immune-cell responses to brain tumours that don’t usually respond to immunotherapy. The findings also point to how to improve such treatments.
Medical subject headings
- Glioblastoma
- T-Lymphocytes